I detail why it will likely beat the Nasdaq 100 in 2025.

is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

Expand Energy started with Outperform rating at J.P. Morgan, citing large-scale exposure to natural gas as the largest producer in the U.S. and the trend of growing natgas demand.

Shares of Kymera Therapeutics (NASDAQ:KYMR) spiked on Tuesday after the developer of oral protein degraders outlined its 2025 outlook at the ongoing J.P. Morgan Healthcare Conference. According to the company,

Ollie's Bargain Outlet Holdings (NASDAQ:OLLI) was one of the biggest gainers in the consumer sector on Thursday after J.P. Morgan added the stock to its Analyst Focus List on its view the retailer ...

I am pleased to announce that Sotera Health delivered another year of top-line growth in 2024,” said Mr. Petras. “We expect full-year revenues will be approximately $1.1 billion, representing growth of nearly 5% versus 2023 and more than 5% growth on a constant currency basis.

Summit Therapeutics recently presented their latest developments at the 43rd Annual J.P. Morgan Healthcare Conference. The event featured discussions led by Bob Duggan, the Chairman & CEO ...

He cut Federated Hermes ( NYSE: FHI) to Neutral from Overweight, partly due to lost market share in money funds and partly due to a "less compelling interest rate environment." J.P. Morgan sees "compelling secular tailwinds,

today announced that it will participate in the J.P. Morgan 43rd Annual Healthcare Conference, January 12-16, 2025. BioUtah President and CEO, Kelvyn Cullimore, will attend on behalf of the ...

Expand Energy (NASDAQ:EXE) +2.7% in Thursday's trading to an all-time high of $108.83 as J.P. Morgan launches coverage with an Outperform rating and $112 price target, citing large-scale exposure ...

A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be available within 48 hours following the conclusion of the conference and archived on the Company's website.

Shares of Kymera Therapeutics (NASDAQ:KYMR) spiked on Tuesday after the developer of oral protein degraders outlined its 2025 outlook at the ongoing J.P. Morgan Healthcare Conference. According to ...